Search on Site

Explore our comprehensive database of pharmaceutical news releases, press releases, events, and industry insights with ease. Effortlessly find relevant information tailored to your interests and stay updated on the latest developments in the pharmaceutical sector. Start searching now to uncover valuable insights and resources for your pharmaceutical endeavors.

UPSHER-SMITH LAUNCHES METHIMAZOLE TABLETS, USP

Upsher-Smith Laboratories, LLC (Upsher-Smith) announced the recent launch of Methimazole Tablets, USP, 5 mg and 10 mg. The Methimazole Tablet market had U.S. sales of approximately $36.8 million for the 12 months ending December 2023 according to...

Nested Therapeutics Receives FDA Clearance for IND Application of NST-628, a Groundbreaking Pan-RAF/MEK Molecular Glue

already activated, we look forward to dosing the first patients in this trial in the first half of this year." The Phase 1 open-label, single-arm, two-part study (NCT06326411) is intended to investigate the safety, pharmacokinetics (PK),...

Neurocrine Biosciences begins Phase 1 trial on NBI-1065890, a second-gen VMAT2 inhibitor, in healthy adults

Neurocrine Biosciences, Inc. announced the initiation of its Phase 1 clinical study to evaluate the safety, tolerability, pharmacokinetics, and pharmacodynamics of investigational compound NBI-1065890 in healthy adult participants. NBI-1065890 is...

Brainomix's AI-Powered e-Lung, Developed with AstraZeneca, Improves Identification of Lung Fibrosis Patients at Risk

of a new study in the prestigious peer-reviewed journal American Journal of Respiratory and Critical Care Medicine (AJRCCM)1, resulting from a research collaboration AstraZeneca, the UK's leading Biopharmaceutical company. The results showed that...

Akebia's Vafseo® (vadadustat) Tablets FDA Approved for Anemia Treatment in Dialysis Patients

in August 2020. Results from the INNO2VATE program were published in the New England Journal of Medicine: (N Engl J Med 2021; 384:1601-1612); (N Engl J Med 2021; 384:1589-1600). See the Important Safety Information section below, including BOXED...

CorDx Receives Emergency Use Authorization

and other medical devices, recently received Emergency Use Authorization (EUA) for its CorDx Tyfast Flu A/B & COVID-19 Multiplex Rapid Test. The 3-in-1 multiplex test is a lateral flow immunoassay device intended for the qualitative detection and...

BioTRUST Nutrition® Launches Eternal Mind® Featuring Nutricog®

critical neurochemicals involved in cognitive function, healthy memory, and long-term mental fitness; and Vitamins B6 and B12, two brain vitamins that support brain energy production, neurotransmitter synthesis, and homocysteine detoxification....

Telix's TLX250-CDx: First Patient Dosed in Italian Early Access Program for Kidney Cancer Imaging

successful global Phase III ZIRCON study (Zirconium in Renal Cancer Oncology, ClinicalTrials.gov Identifier: NCT03849118), which reported positive results in November 2022, meeting all co-primary and secondary endpoints.[2] Arturo Chiti, Professor...

Gedeon Richter Chooses Trial Interactive for Streamlined Clinical Trial Management

pharmaceutical, biotechnology, medical device, and CRO companies to streamline product development lifecycles in a secure, 21 CFR Part 11-compliant environment. By offering a fully integrated, AI-enhanced user experience, Trial Interactive improves...

Aptamer Sciences Inc.Innovative Liver Cancer Treatment AST-201

Aptamer Sciences Inc. (KOSDAQ, 291650) announced the filing of an Investigational New Drug (IND) application for the phase 1 clinical trial of AST-201. AST-201, the company's pioneering candidate in its pipeline, is an ApDCTM (Aptamer-Drug...

Translational Vision Science and Technology Journal Publishes RadiusXR's NOVA Clinical Trial

locations, glaucoma staging using Medicare definitions, and an exceptionally high correlation of 0.94 in mean deviation.1 These results underscore the unparalleled accuracy and reliability of RadiusXR's approach to visual field testing for...

Brazilian Entrepreneur Launches Entourage Phytolab on One Lavi

– Night Use features include: Fast-Acting: The patented Fusionner technology promises swift relief, with an onset of just 15 minutes. Enhanced Absorption: With a 50% surge in bioavailability, the technology optimizes the body's absorption rates....

Sapience Therapeutics to Present Multiple Posters at the American Association for Cancer Research

Research (AACR). Sapience will present non-clinical immunotherapy results at AACR from both of its clinical programs, ST316, a first-in-class antagonist of β-catenin, and ST101, a first-in-class antagonist of C/EBPβ. Sapience will also present...

Ginkgo Technology Network Launches, Providing an Integrated R&D

to collaborating with Ginkgo to provide new, integrated capabilities to drive success in customer R&D programs. For over 15 years, Ginkgo has invested in building and integrating horizontal platform technologies to serve a diverse set of customer...

SK bioscience Receives WHO Prequalification for Typhoid Conjugate Vaccine

from the World Health Organization (WHO). For its typhoid conjugate vaccine (TCV), 'SKYTyphoid®' (project name NBP618). This the fourth WHO PQ the company has received following its two influenza vaccines and varicella vaccine. The WHO PQ system...

Qualia NAD+ Shown In Preliminary Clinical Study To Increase NAD+ By 85%

promise, or reflection of other users' results. About Neurohacker Collective: Neurohacker Collective was established in 2015 to enhance the quality of life through cutting-edge well-being formulations. Their science team emphasizes the principles...

HemoSonics' Quantra® Hemostasis System

with QPlus and QStat Cartridges provides comprehensive whole-blood coagulation analysis at the point of care in less than 15 minutes. Named after the American inventor Thomas Alva Edison, the Edison Awards recognize the world's most innovative...

Improved Pharma Brings Onboard Micro-DSC Hot-Stage System

Microscopy for evaluating the thermal properties of micro-quantities of materials. The newly-added Mettler-Toledo HS84/HS1 DSC controller micro-DSC system is the only true DSC hot stage on the market, and will allow visual observation of thermal...

Tetra Pharm Technologies advances CB1 antagonist, TPT0701, for appetite suppression into preclinical testing

endocannabinoid system (ECS), Tetra Pharm Technologies, is moving forward with its compound for appetite suppression, TPT0701. Endocannabinoid system modulation has long been recognized as a promising avenue for appetite regulation. Through...

Rehabtronics Selected by Praxis Spinal Cord Institute to Launch Prelivia Pilot

show that the number of hospital-acquired pressure injuries (HAPI) has climbed steadily over the past four years (2018-2022) by 43% and is still growing. Pressure injuries are a common medical complication of paralysis and immobility, and people...